GlassScriptPhysician profile
Pamala Kuchta
NPI 1992975361
$3,255.69
in general payments reported to CMS, 2019-2025
9 companies · $179 in 2025
The $179 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $235 · 2022: $471 · 2023: $58.26 · 2024: $2,312 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,747 · Food and Beverage: $802.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,747.26 |
| Food and Beverage | $802.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,036.91 | 2024 | |
| Pinnacle Biologics, INC | $298.58 | 2022-2024 | Photofrin |
| Medtronic, INC. | $207.05 | 2021-2023 | Signia |
| Becton, Dickinson and Company | $178.97 | 2025 | Surgiphor |
| Depuy Synthes Sales INC. | $141.11 | 2022 | |
| Pulmonx Corporation | $130.67 | 2024 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Astrazeneca Pharmaceuticals LP | $121.35 | 2021 | |
| Davol INC. | $90.35 | 2021 | |
| Atricure, INC. | $50.70 | 2023-2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pamala Kuchta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.